Skip to main content
. Author manuscript; available in PMC: 2018 Sep 14.
Published in final edited form as: Clin Res (Alex). 2018 Aug 14;32(7):https://www.acrpnet.org/2018/08/14/african-american-screening-and-enrollment-in-the-clear-iii-trial/.

Table 3.

Screen Failure Categories (N = 7,298)

AA Non-AA P-value
N % N %
Medical 1,292 73.6% 4,581 82.7% <0.001

Abnormal PTT, PLT < 100K, INR > 1.3 34 1.9% 122 2.2% 0.503

Age < 18 or > 80 years 98 5.6% 884 16.0% <0.001

Aneurysm, mycotic aneurysm, moyamoya, etc. 161 9.2% 743 13.4% <0.001

Craniectomy/other surgical procedures 21 1.2% 51 0.9% 0.308

Etiology - tumor 3 0.2% 47 0.8% 0.003

GCS < 3/herniation/brain dead/deceased 25 1.4% 43 0.8% 0.014

Historic (pre-bleed) Rankin not 0 or 1 47 2.7% 96 1.7% 0.013

ICH > 30 cc on diagnostic CTC 256 14.6% 700 12.6% 0.035

Infratentorial bleed 150 8.5% 451 8.1% 0.591

No EVD placed 220 12.5% 733 13.2% 0.449

No obstruction of 3rd and/or 4th 261 14.9% 636 11.5% <0.001

Unstable bleeding 16 0.9% 75 1.4% 0.146

Non-medical 199 11.3% 471 8.5% <0.001

Improper screening 9 0.5% 21 0.4% 0.446

Participation in another trial 6 0.3% 10 0.2% 0.208

Patient eligible but refused consent 54 3.1% 66 1.2% <0.001

Patient is DNR 59 3.4% 250 4.5% 0.037

Study staff not notified within window 11 0.6% 21 0.4% 0.171

Study staff unavailable 2 0.1% 8 0.1% 0.764

Unable to dose within time window 58 3.3% 95 1.7% <0.001

Combination medical and non-medical reasons 265 15.1% 490 8.8% <0.001

MD/Surgeon chose not to enroll 56 3.2% 65 1.2% <0.001

Not an IVH patient 18 1.0% 49 0.9% 0.59

Other 191 10.9% 376 6.8% <0.001

Total 1,756 100.0% 5,542 100.0%